Evercore ISI Keeps Their Buy Rating on Healthpeak Properties (DOC)
In a report released today, James Kammert from Evercore ISI maintained a Buy rating on Healthpeak Properties, with a price target of $22.00.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Kammert covers the Real Estate sector, focusing on stocks such as Healthpeak Properties, Alexandria Equities, and Agree Realty. According to TipRanks, Kammert has an average return of 0.7% and a 46.30% success rate on recommended stocks.
Healthpeak Properties has an analyst consensus of Moderate Buy, with a price target consensus of $19.09.
Based on Healthpeak Properties’ latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of $705.87 million and a GAAP net loss of $117.12 million. In comparison, last year the company earned a revenue of $700.4 million and had a net profit of $85.87 million
Read More on DOC:
Disclaimer & DisclosureReport an Issue
- Healthpeak Properties price target lowered to $18 from $19 at Wells Fargo
- Healthpeak Unveils Janus Living IPO and Portfolio Strategy
- Healthpeak Properties reports Q4 FFO 47c, consensus 45c
- Healthpeak Properties sees FY26 FFO $1.70-$1.74, consensus $1.84
- Physicians Realty Trust options imply 3.0% move in share price post-earnings
